Should Increased Breast Density Dictate More Breast Cancer Screenings?

Share this content:
Whether women with dense breast tissue should have additional breast screenings remains unclear.
Whether women with dense breast tissue should have additional breast screenings remains unclear.

Increased breast density is associated with an increased risk for breast cancer, as small tumors might be missed on a mammogram of dense breasts. However, whether increased screening should be provided to women with dense breast tissue remains unclear. Both the US Preventive Services Task Force (USPSTF) and the American College of Radiology (ACR) recommend against magnetic resonance screening. However, the ACR advises that ultrasonography for supplemental screening should be considered for women with dense breasts. The issues were evaluated by 2 experts in a report published in Annals of Internal Medicine

Christoph I. Lee, MD, MS, a radiologist, notes that 43% of women have dense breast tissue. However, the definition of “dense” is subjective. There is no universal classification for dense breast tissue. Different radiologists may score breast density differently from one mammogram to the next, even for the same patient. General internist Joann G. Elmore, MD, MPH, concurs. The 2 also agree that breast density is not an abnormality and that family history is a stronger indicator of potential breast cancer risk than breast density. 

Dr Lee recommends digital breast tomosynthesis (DBT) as opposed to film mammography. He argues that DBT improves sensitivity for cancer detection, whereas Dr Elmore contests that while DBT might decrease the number of false positives, it may increase radiation exposure. Elmore further noted that increased screening can also lead to false positives, increased patient anxiety, overdiagnosis, overtreatment, and increased costs.

Both physicians stress the importance of informed patient-provider discussions about the effect of breast density. Dr Lee recommends, “shared decision making and suggests that automated estimates of lifetime risk may allow radiologists to provide more helpful counsel in their results letters.”

Reference

Smetana GW, MD, Elmore JG, Lee CI, Burns RB. Should this woman with dense breasts receive supplemental breast cancer screening?: Grand Rounds discussion from Beth Israel Deaconess Medical CenterAnn Intern Med. 2018;169(7):474-484.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs